Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Summit Therapeutics (SMMT)
Technical Analysis Report for USA stock SMMT Summit Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics then click here. or read Experts views on Summit Therapeutics or Forecast & share price targets of Summit Therapeutics
Summit Therapeutics Opened at 13.88 and Closed at: 14.97, which is 7.48% of previous session's close. It moved within a range of 13.88 and 15.11
The session was a Bullish session with an average volume of 1126564, which is -240.32% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 14.43 and resistance for tomorrow is 15.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 14.2, 13.42 resistance for tomorrow's hourly charts is 15.43, 15.88
10 Day SMA for Summit Therapeutics (SMMT) is 14.98 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Summit Therapeutics (SMMT) is 16.1 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Summit Therapeutics (SMMT) is 17.16 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 18.34 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Summit Therapeutics is 21.28 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Summit Therapeutics is at 16.1 and 200 DMA is at 21.28, while 50 DMA and 100 DMA are at 17.16 and 18.34 respectively
Summit Therapeutics (SMMT) moving average of 20 SMA is at 16.1 and 20 EMA is at 15.78
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 14.97 | 16.1 | 15.78 |
| 05 Thu Feb | 13.85 | 16.3 | 15.87 |
| 04 Wed Feb | 14.42 | 16.56 | 16.08 |
| 03 Tue Feb | 14.57 | 16.77 | 16.25 |
| 02 Mon Feb | 14.06 | 16.91 | 16.43 |
| 30 Fri Jan | 14.45 | 17.08 | 16.68 |
Summit Therapeutics (SMMT) moving average of 50 SMA is at 17.16 and 50 EMA is at 16.97
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 14.97 | 17.16 | 16.97 |
| 05 Thu Feb | 13.85 | 17.22 | 17.05 |
| 04 Wed Feb | 14.42 | 17.27 | 17.18 |
| 03 Tue Feb | 14.57 | 17.31 | 17.29 |
| 02 Mon Feb | 14.06 | 17.35 | 17.4 |
| 30 Fri Jan | 14.45 | 17.4 | 17.54 |
Summit Therapeutics (SMMT) moving average of 100 SMA is at 18.34 and 100 EMA is at 18.33
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 14.97 | 18.34 | 18.33 |
| 05 Thu Feb | 13.85 | 18.38 | 18.4 |
| 04 Wed Feb | 14.42 | 18.43 | 18.49 |
| 03 Tue Feb | 14.57 | 18.48 | 18.57 |
| 02 Mon Feb | 14.06 | 18.51 | 18.65 |
| 30 Fri Jan | 14.45 | 18.55 | 18.74 |
Summit Therapeutics (SMMT) moving average of 200 SMA is at 21.28 and 200 EMA is at 19.4
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 14.97 | 21.28 | 19.4 |
| 05 Thu Feb | 13.85 | 21.33 | 19.44 |
| 04 Wed Feb | 14.42 | 21.37 | 19.5 |
| 03 Tue Feb | 14.57 | 21.42 | 19.55 |
| 02 Mon Feb | 14.06 | 21.46 | 19.6 |
| 30 Fri Jan | 14.45 | 21.5 | 19.66 |
Novartis Ag has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Novartis Ag, about 34.44% more returns!
Mednax Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Mednax Inc, about 17.44% more returns!
Voyager Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 15.47% more returns!
Utah Medical has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Utah Medical, about 26.83% more returns!
Twist Bioscience has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 63.34% more returns!
Trupanion Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Trupanion Inc, about 16.17% more returns!
Oramed Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 23.35% more returns!
Livanova Plc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 27.27% more returns!
Ensign Group has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Ensign Group, about 37.69% more returns!
Dexcom Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 27.74% more returns!
Corcept Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 32.87% more returns!
Beyondspring Inc has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Beyondspring Inc, about 18.27% more returns!
Axsome Therapeutics has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 31.71% more returns!
Summit Therapeutics has performed better than Alphatec Holdings in short term. Holding Summit Therapeutics could be a better choice for now!
Argenx Se has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Argenx Se, about 26.84% more returns!
Apellis Pharmaceuticals has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 9.94% more returns!
Acadia Healthcare has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 22.75% more returns!
Aceto Corporation has performed better than Summit Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 11.48% more returns!
Summit Therapeutics Technical analysis of indicators
Price action analysis of Summit Therapeutics (SMMT) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Summit Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Summit Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.74 and Summit Therapeutics SMMT stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics SMMT stock. Volume based technical analysis of Summit Therapeutics SMMT stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SMMT Summit Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SMMT Experts View which covers a lot of information including buying and selling signals
SMMT future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Summit Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Summit Therapeutics (SMMT) Technical (Analysis) Reports Summit Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


